Publications
Specialty
Search
Wound Care
07/16/2024
A 250-patient study will investigate the efficacy and safety of allo-APZ2-CVU administered topically for treatment of non-healing venous ulcers with the primary outcome of complete wound closure at 18 weeks. Not yet recruiting; estimated study completion is Sept 2027. clinicaltrials.gov
Wound Care
07/16/2024
Spectral AI announced the signing of a MOU with PolyNovo under which the companies will collaborate to assist Spectral AI in a potential limited deployment of its DeepView System for burn indication in Australia.
Wound Care
07/16/2024
Kerecis announced the expansion of its silicone fish-skin graft combination product range with Shield Spiral, which offers advanced customizable wound care solutions. The product features perforated fenestration marks cut in a unique spiral pattern, allowing easy customization.
Wound Care
07/16/2024
A study that evaluated the efficacy and safety of PRP gel prepared using TKKT01 (a processing device candidate by Rohto Pharmaceutical of Japan) in patients with hard-to-heal DFUs met the primary endpoint with 38/47 (80.9%) patients achieving ≥ 50% wound radius reduction. JOWC
EMSWorld
07/16/2024
Toxicity from hydrofluoric acid can be dangerous, and secondary contamination is a risk to EMS providers. If a patient spills it on themselves, what should their provider do?
Wound Care, Wounds
07/16/2024
In the first 3 installments of our Wound Care Wednesday series, Dr. Jonathan Johnson and his guests discuss the foundations of wound healing with a focus on cellular, acellular, and matrix products.
Psych Congress Network
07/16/2024
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Neurology
07/16/2024
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Rheumatology & Arthritis
07/16/2024
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Psych Congress Network
07/16/2024
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
Psych Congress Network
07/16/2024
Do you remember this insight from Dr Jain?
Annals of Long-Term Care
07/16/2024
"A common barrier for the medically frail and terminally ill populations is the inability to work due to their illness. Not being able to pay their rent and various bills can lead to an eviction, starting the cycle of homelessness," said Jillian Olmsted.
Podiatry Today
07/16/2024
Dr. Cole dives into the importance of antimicrobial stewardship.
Cath Lab Digest, Vascular Disease Management, Journal of Invasive Cardiology, CardioVascular
07/16/2024
“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.
Oncology
07/16/2024
According to results from the innovaTV 301 trial, tisotumab vedotin significantly improved efficacy outcomes compared to chemotherapy in the second-or third-line setting among patients with recurrent or metastatic cervical cancer.
Oncology
07/16/2024
At the 2024 Pan Pacific Lymphoma Conference, Elaine Jaffe, MD, analyzes the differing classification systems of lymphoma, focusing on diffuse large B-cell lymphoma, follicular lymphoma, and small B-cell neoplasms.
Wound Management & Prevention
07/15/2024
Vincenzo Pedace, MD1; Marco Della Valle, RN1; Coloplast Ostomy Forum; and Nurse Expert Panel
Psych Congress Network
07/15/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Psych Congress Network
07/15/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Neurology, Psych Congress Network
07/15/2024
Charles Raison, MD, discusses first-line treatment options for insomnia.